Skip to content

Comparison of Aspirin dose in prevention of preeclampsia and maternal fetal complications

Comparison of Aspirin dose (80 and 160 mg) in prevention of preeclampsia and maternal fetal complications

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190826044619N1
Enrollment
80
Registered
2020-02-04
Start date
2018-03-21
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia. Pre-eclampsia

Interventions

Intervention 1: Intervention group: Pregnant women who will take aspirin 160 mg.The 80 mg Aspirin by the Jalinus Pharmaceutical Company will be used orally 2 times a day from the time of study until t

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The pregnant mother has completed the consent form to participate in the study. Pregnant mother is 12 to 16 weeks pregnant. The pregnant mother has at least one of the following criteria: a history of previous preeclampsia, polygamy, chronic hypertension, type 1 and type 2 diabetes, kidney disease, autoimmune disease (such as lupus). Or the pregnant mother has at least two of the following criteria: nulliparity, obesity, age over 35, low level of socioeconomic status, gap between pregnancies over 10 years, adverse pregnancy outcome (stillbirth, etc.)

Exclusion criteria

Exclusion criteria: The pregnant mother has peptic ulcer. The pregnant mother has gout.

Design outcomes

Primary

MeasureTime frame
Preeclampsia. Timepoint: Each 2 week from 20 to 28 weeks of gestational age and after that weekly until the termination of pregnancy. Method of measurement: Systolic blood pressure greater than 1 mmHg or diastolic blood pressure greater than 1 mmHg.

Secondary

MeasureTime frame
Preterm delivery. Timepoint: Mother's delivery. Method of measurement: Maternal gestational age is less than 37 weeks.;Method of childbirth. Timepoint: Mother's delivery. Method of measurement: Cesarean section or Vaginal delivery.;Intrauterine fetal growth restriction. Timepoint: Every two weeks from the start of the intervention until the 28th week of pregnancy. Method of measurement: sonography.;Apgar score minute1. Timepoint: 1 minute after birth. Method of measurement: Grading to Appearance, Pulse, Grimace, Activity and Respiration of baby.;Apgar score minute 5. Timepoint: 5 minutes after birth. Method of measurement: Grading to Appearance, Pulse, Grimace, Activity and Respiration of baby.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Chamani

Iran University of Medical Sciences

chamani.m@iums.ac.ir+98 21 8856 2080

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026